Shirisha (Albizia lebbeck): The Ayurvedic Tree for Allergies

Shirisha (Albizia lebbeck, sometimes called the "woman's tongue tree" or "East Indian walnut") is a large tree of the mimosa family whose bark and seeds hold a particular place in classical Ayurvedic pharmacopoeia: they are traditionally associated with the allergic and respiratory terrain — runny nose, repeated sneezing, mild bronchial discomfort. Ancient texts (notably the Charaka Samhita) classify it among the "kaphahara" herbs useful for the ENT sphere, a use that recent pharmacological research has begun to document in animal models.

It is neither an antihistamine nor a treatment for asthma: shirisha fits within a terrain-based logic, alongside medical follow-up, never in its place — a point this article returns to in detail further below.

What is shirisha? A botanical overview

Native to the Indian subcontinent and Southeast Asia, Albizia lebbeck is a tree that can exceed 50–65 feet (15–20 m), recognizable by its large flat pods that rattle against each other in the wind — hence some of its popular nicknames ("woman's tongue tree"). In Ayurveda, the parts mainly used are:

• the trunk bark, dried then ground into powder or prepared as a decoction;
• the seeds, used less often, in composite traditional formulations;
• occasionally the leaves, for external use.

Shirisha sits close, in its logic of use for the respiratory sphere, to other herbs already covered on the site such as vasaka for coughs and bronchial congestion, or tulsi for everyday respiratory comfort — but its area of use remains specifically allergic in nature, more than purely infectious or expectorant.

Shirisha and the allergic terrain: what does tradition say, what does research say?

This is the most documented use, both historically and scientifically. Ayurvedic tradition attributes to shirisha bark a "dehumidifying" and soothing action on mucous membranes affected by excess Kapha, a terrain classically associated with hay fever, rhinitis and mild asthma. Classical formulations such as Shirishavaleha (a preparation based on shirisha bark) remain in use in Indian clinical Ayurveda for this terrain.

On the pharmacological side, several laboratory studies point in the same direction:

• A study by Venkatesh and colleagues, published in 2010 in Immunopharmacology and Immunotoxicology, showed that a standardized Albizia lebbeck bark extract (using catechin as a marker compound) exerts a mast-cell-stabilizing action in mice, comparable to the mechanism of certain reference anti-allergy treatments — a mechanism that limits histamine release (see the study on Google Scholar).
• A study by Nurul, Mizuguchi, Fukui and colleagues, published in 2011 in International Immunopharmacology, tested a shirisha bark extract on an animal model of allergic rhinitis: treated animals sneezed and rubbed their noses significantly less, with reduced expression of histamine receptors in the nasal mucosa (see the study on Google Scholar).

These results are promising but preliminary: they are laboratory studies (mice, rats, cells), not large-scale human clinical trials. They confirm a pharmacological pathway consistent with traditional use, without amounting to established clinical proof of efficacy. For an overview of the Ayurvedic strategy for seasonal allergies, see also our article seasonal allergies: the Ayurvedic approach to hay fever.

Other traditional uses: skin, bites and joints

Beyond the respiratory sphere, tradition credits shirisha bark and leaves, used externally, with a soothing role on insect bites and skin itching — a poultice or decoction applied locally. Some composite preparations also link it, more marginally, to joint comfort. These uses are far less studied than the allergic terrain and rest almost exclusively on tradition: they should be considered a lifestyle complement, not a validated targeted treatment.

What form and what dosage?

Shirisha remains uncommon in Western countries: it is mostly found through herbalists specializing in Ayurvedic herbs or through trained practitioners, rarely on general retail shelves. As an indicative guide, based on reported traditional uses:

Plant part	Traditional use	Most common form
Trunk bark	Allergic and respiratory terrain (rhinitis, mild asthma), cough	Powder (churna) or decoction (kwath)
Seeds	More occasional use, composite formulations	Powder in combination
Leaves	External use: bites, skin itching	Poultice or decoction applied locally

Traditional dosages of the bark powder often sit around 2 to 4 grams per day, split into one or two doses, generally taken with a little honey in classical preparations. This figure remains indicative: there is no dosage validated by human clinical trials, and commercial supplements (where they exist) should be dosed according to the manufacturer's label. Shirisha is taken as a course lasting several weeks, never as a one-off response to a flare-up.

Shirisha and the doshas

In the Ayurvedic reading, the allergic terrain and chronic rhinitis are most often read as a Kapha imbalance (excess mucus, heaviness of the mucous membranes), sometimes compounded by excess Vata, which weakens tissues and airway reactivity. Shirisha is traditionally considered soothing for both these doshas in this specific context, without being an aggressively "heating" herb for Pitta at a reasonable dose. To learn more about your own profile and its respiratory weak points, see our Kapha dosha and Vata dosha pages.

Precautions: what shirisha is not

This is the most important point of this article. Shirisha is neither an asthma treatment nor a treatment for a severe allergy. Even when described as "mild," asthma remains a disease that must be diagnosed and medically monitored: airflow measurements, any baseline treatment, an action plan for flare-ups. No herb, shirisha included, replaces this follow-up.

• Diagnosed asthma: shirisha never substitutes for a prescribed baseline treatment or bronchodilator. Any herb considered as a complement should be discussed with your treating physician or pulmonologist, never by stopping or spacing out a prescribed treatment on your own.
• Severe allergy or anaphylaxis risk: this is not a case for herbal self-medication. A history of a severe allergic reaction requires allergist follow-up, with prescribed emergency medication always on hand.
• Respiratory emergency: worsening breathing difficulty, marked wheezing, bluish lips, inability to finish a sentence, swelling of the face or throat, feeling faint — these are signs of a medical emergency. Call emergency services or go to the emergency room; do not take a tea or capsule instead.
• Pregnancy, breastfeeding, young children: for lack of solid human safety data, shirisha is discouraged as a precaution in these situations, unless a qualified practitioner advises otherwise.
• Interactions and ongoing treatments: as with any herb aimed at the immune or allergic system, ask a health professional if you are on antihistamine, corticosteroid or immunomodulatory treatment.
• Herb quality: since shirisha is uncommon in Western countries, favor a source that guarantees the exact species (Albizia lebbeck) and the absence of contamination — the general vigilance points for imported Ayurvedic herbs (heavy metals, adulteration) are detailed in our safety and precautions guide, worth reading before any course.

In short: shirisha is a terrain herb, to be considered as a long-term companion to a lifestyle suited to a Kapha or Vata profile, never as a response to a flare-up or a substitute for a diagnosis and medical follow-up of the respiratory system.